GAIN THERAPEUTICS, INC Capitalized Computer Software, Amortization
GAIN THERAPEUTICS, INC (GANX) reported Capitalized Computer Software, Amortization of $12.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CapitalizedComputerSoftwareAmortization1 · last filed 2026-08-11
- GAIN THERAPEUTICS, INC capitalized computer software, amortization for the quarter ending 2026-06-30 was $12.00K, a 0.00% change year-over-year.
- GAIN THERAPEUTICS, INC capitalized computer software, amortization for the quarter ending 2026-03-31 was $12.00K, a 9.09% increase year-over-year.
- GAIN THERAPEUTICS, INC capitalized computer software, amortization for the quarter ending 2025-12-31 was $13.00K, a 8.33% increase year-over-year.
- GAIN THERAPEUTICS, INC capitalized computer software, amortization for the quarter ending 2025-09-30 was $13.00K, a 8.33% increase year-over-year.
- GAIN THERAPEUTICS, INC capitalized computer software, amortization for fiscal 2025 was $49.00K, a 4.26% increase from fiscal 2024.
- GAIN THERAPEUTICS, INC capitalized computer software, amortization for fiscal 2024 was $47.00K, a 2.17% increase from fiscal 2023.
- GAIN THERAPEUTICS, INC capitalized computer software, amortization for fiscal 2023 was $46.00K, a 22.55% increase from fiscal 2022.
- GAIN THERAPEUTICS, INC capitalized computer software, amortization for fiscal 2022 was $37.54K.
| Period end | Capitalized Computer Software, Amortization 3 month | Capitalized Computer Software, Amortization 6 month | Capitalized Computer Software, Amortization 9 month | Capitalized Computer Software, Amortization 12 month | Capitalized Computer Software, Amortization 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $12.00K 10-Q · filed 2026-08-11 | $25.00K 10-Q · filed 2026-08-11 | $37.00K derived: sum of 3 quarters · filed 2026-08-11 | $50.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $12.00K 10-Q · filed 2026-05-11 | $25.00K derived: sum of 2 quarters · filed 2026-05-11 | $38.00K derived: sum of 3 quarters · filed 2026-05-11 | $50.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $26.00K derived: sum of 2 quarters · filed 2026-03-26 | $38.00K derived: sum of 3 quarters · filed 2026-08-11 | $49.00K 10-K · filed 2026-03-26 | |
| 2025-09-30 | $13.00K 10-Q · filed 2025-11-12 | $25.00K derived: sum of 2 quarters · filed 2026-08-11 | $36.00K 10-Q · filed 2025-11-12 | $48.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | $12.00K 10-Q · filed 2026-08-11 | $24.00K 10-Q · filed 2026-08-11 | $35.00K derived: sum of 3 quarters · filed 2026-08-11 | $47.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $11.00K 10-Q · filed 2026-05-11 | $23.00K derived: sum of 2 quarters · filed 2026-05-11 | $35.00K derived: sum of 3 quarters · filed 2026-05-11 | $46.00K derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $24.00K derived: sum of 2 quarters · filed 2026-03-26 | $35.00K derived: sum of 3 quarters · filed 2026-03-26 | $47.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $12.00K 10-Q · filed 2025-11-12 | $23.00K derived: sum of 2 quarters · filed 2025-11-12 | $35.00K 10-Q · filed 2025-11-12 | $47.00K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $11.00K 10-Q · filed 2025-08-12 | $23.00K 10-Q · filed 2025-08-12 | $35.00K derived: sum of 3 quarters · filed 2025-08-12 | $48.00K derived: sum of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | $12.00K 10-Q · filed 2025-05-14 | $24.00K derived: sum of 2 quarters · filed 2025-05-14 | $37.00K derived: sum of 3 quarters · filed 2025-05-14 | $47.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $25.00K derived: sum of 2 quarters · filed 2025-03-27 | $35.00K derived: sum of 3 quarters · filed 2025-03-27 | $46.00K 10-K · filed 2025-03-27 | $45.51K 10-K · filed 2024-03-26 |
| 2023-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $23.00K derived: sum of 2 quarters · filed 2024-11-14 | $34.00K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $21.00K 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | $11.00K 10-Q · filed 2024-05-14 | ||||
| 2022-12-31 | $37.54K 10-K · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |